Skip to content
User

Ronald Muhlenkamp

Muhlenkamp & Co

Ronald Muhlenkamp COVIDIEN LTD stake

total: 197

Muhlenkamp & Co F113PS trades

Total transactions:
7
New positions:
1
Sold out:
1
Added:
3
Reduced:
2
Held since:
2013 Q2 or earlier
Held for:
7+ quarters
Latest activity:
2015 Q1
According to 2026 Q2 report, Ronald Muhlenkamp doesn't hold any COVIDIEN LTD (F113PS) shares. Muhlenkamp & Co has held F113PS since at least 2013 Q2 with 174,170 shares in our earliest available record. Since at least 2013 Q2, Muhlenkamp & Co has made 6 more transactions.

When did Ronald Muhlenkamp sell COVIDIEN LTD (F113PS)?

Ronald Muhlenkamp sold off the entire COVIDIEN LTD (F113PS) position in 2015 Q1.

Estimated cost basis*

Weighted AVG buy price:
$63.15
Weighted AVG sell price:
$102.25

Ronald Muhlenkamp's historical trades in COVIDIEN LTD

7 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2015 Q1
0.00%
$102.28
-100% (-181,650)
2014 Q4
3.75%
$102.28
-0.29% (-530)
2014 Q2
2.92%
$90.18
+0.40% (+725)
2014 Q1
2.37%
$73.66
-0.10% (-180)
2013 Q4
2.19%
$68.10
+4.02% (+7,015)
2013 Q3
2.14%
$60.94
+0.26% (+450)
2013 Q2
2.31%
$62.84
new or own*
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.